Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience

Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases

(2010) Peter C Taylor   CURRENT OPINION IN PHARMACOLOGY

The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease☆

(2010) Ambrogio Orlando et al.   DIGESTIVE AND LIVER DISEASE

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

(2010) A. Dignass et al.   Journal of Crohns & Colitis

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis

(2009) Z. YANG et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis

(2009) M. Ferrante et al.   INFLAMMATORY BOWEL DISEASES

Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery

(2009) Liliana Bordeianou et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Preoperative Steroid Use and Risk of Postoperative Complications in Patients With Inflammatory Bowel Disease Undergoing Abdominal Surgery

(2008) Venkataraman Subramanian et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials

(2008) Laurent Peyrin–Biroulet et al.   Clinical Gastroenterology and Hepatology

Infliximab in Crohn's disease: early and long-term treatment

(2008) A. Armuzzi et al.   DIGESTIVE AND LIVER DISEASE

Infliximab in Ulcerative Colitis is Associated with an Increased Risk of Postoperative Complications After Restorative Proctocolectomy

(2008) I. J. Mor et al.   DISEASES OF THE COLON & RECTUM

European evidence-based Consensus on the management of ulcerative colitis: Current management

(2008) S.P.L. Travis et al.   Journal of Crohns & Colitis

Perioperative Treatment with Infliximab in Patients with Crohn’s Disease and Ulcerative Colitis is Not Associated with an Increased Rate of Postoperative Complications

(2008) Hiroko Kunitake et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients

(2008) Kweku A. Appau et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

(2008) Geert D'Haens et al.   LANCET